LEF1 regulates breast cancer cell proliferation [72], and IGF2R enhances tumor cell invasion and migration [73] and serves as a poor prognostic marker in triple-negative breast cancer patients [74]. The gene discussed is IGF2R; the disease is breast carcinoma.